SI-B003 + Izalontamab

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

SI-B003 + Izalontamab
Treatment and conditionWhere it standsTrials
SI-B003 + Izalontamab for squamous cell carcinoma of head and neckPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1